Project iFIT-ATM Kinase Inh. – Development of novel Inhibitors of ATM-kinase and their evaluation in combination with RPA3…

Basic data

Acronym:
iFIT-ATM Kinase Inh.
Title:
Development of novel Inhibitors of ATM-kinase and their evaluation in combination with RPA3 inhibitors in anti-tumor therapies.
Duration:
01/09/2019 to 31/08/2021
Abstract / short description:
Development of novel Inhibitors of ATM-kinase and their evaluation in combination with RPA3 inhibitors in anti-tumor therapies.

Involved staff

Managers

Faculty of Science
University of Tübingen
Pharmaceutical Institute
Department of Pharmacy and Biochemistry, Faculty of Science

Other staff

Department of Pharmacy and Biochemistry
Faculty of Science
Pharmaceutical Institute
Department of Pharmacy and Biochemistry, Faculty of Science
Pharmaceutical Institute
Department of Pharmacy and Biochemistry, Faculty of Science

Local organizational units

Pharmaceutical Institute
Department of Pharmacy and Biochemistry
Faculty of Science

Funders

Bonn, Nordrhein-Westfalen, Germany
Help

will be deleted permanently. This cannot be undone.